Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 65.48M | 2.72 | $ 24.09M |
3/31/2025 | $ 60.51M | 2.49 | $ 24.32M |
12/31/2024 | $ 60.08M | 2.34 | $ 25.62M |
9/30/2024 | $ 47.85M | 1.98 | $ 24.22M |
6/30/2024 | $ 77.37M | 1.33 | $ 57.97M |
3/31/2024 | $ 75.4M | 1.38 | $ 54.83M |
12/31/2023 | $ 69.93M | 1.54 | $ 45.53M |
9/30/2023 | $ 72.62M | 1.67 | $ 43.36M |
6/30/2023 | $ 73.58M | 3.18 | $ 23.11M |
3/31/2023 | $ 55.4M | 1.76 | $ 31.52M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: AssetsC [ $ 60.33M ] / LiabilitesC [ $ 43.9M ]
(=) Current Ratio [ 1.37 ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |